Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Personalized Medicine|May 26, 2018
Personalized medicine: the absence of 'model-changing' financial incentivesPeter KeelingPersonalized Medicine|May 24, 2018
Role of the Opportunity To Test Index in integrating diagnostics with therapeuticsPeter KeelingPharmacogenomics|December 21, 2012
Towards a balanced value business model for personalized medicine: an outlookChristof Koelsch, Joanna Przewrocka, Peter KeelingPersonalized Medicine|May 23, 2018
Driving personalized medicine: capturing maximum net present value and optimal return on investmentMollie Roth, Peter Keeling, Dave SmartNew Biotechnology|June 21, 2012
The economics of personalized medicine: commercialization as a driver of return on investmentPeter Keeling, Mollie Roth, Tom ZietlowExpert Review of Molecular Diagnostics|April 28, 2020
Challenges in the clinical implementation of precision medicine companion diagnosticsPeter Keeling, Jordan Clark, Stephanie FinucaneThe Journal of Molecular Diagnostics : JMD|May 11, 2019
Diagnostics Reform and Harmonization of Clinical Laboratory TestingJeff Schreier, Robert Feeney, Peter KeelingBritish Journal of Nursing (Mark Allen Publishing)|November 3, 2010
Towards IV drug standardization in critical carePeter Keeling, Katie Scales, Susan Keeling, et al.Archives of Biochemistry and Biophysics|June 5, 2004
Involvement of lysine-193 of the conserved "K-T-G-G" motif in the catalysis of maize starch synthase IIaZhong Gao, Peter Keeling, Richard Shibles, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 12, 2011
A retrospective analysis of benzodiazepine sedation vs. propofol anaesthesia in 252 patients undergoing endoscopic retrograde cholangiopancreatographyJeffrey T Lordan, Justin Woods, Peter Keeling, et al.Pageof 2